read more

first_img Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis Augmented Reality Versus 3-D Printing for Radiology Three-dimensional (3-D) printing and… read more News | Advanced Visualization | July 03, 2019 TeraRecon Unveils iNtuition AI Data Extractor Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor… read more Technology | Advanced Visualization | June 13, 2019 Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug… read more Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor Innovations in Radiotherapy and Radiology at Henry Ford Hospital Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res read more Technology | Neuro Imaging | August 07, 2019 Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release… read more Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale Transformations in Molecular Imaging Herald Entry to Novel Applications Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging. read more November 24, 2014 — EDDA Technology announced that the company has received U.S. Food and Drug Administration (FDA) clearance on IQQA-BodyImaging. The new product will be introduced as the latest addition to the IQQA Platform and Product Suite for imaging-guided cancer treatment at the 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago IL Nov. 30-Dec. 5. Also being introduced at RSNA is the company’s cloud-based OnDemand service with its clinical collaborator Massachusetts General Hospital.The IQQA Platform and Product Suite was developed with a specific aim to maximize the utilization of multimodality imaging and its benefit for multiple stakeholders along the cycle of patient care, which include radiologists, interventional radiologists, surgeons and oncologists. By supporting efficient collaboration for optimal workflow and treatment management with clinical depth and OnDemand accessibility, the IQQA Platform enables a patient-specific, disease-targeted and multidisciplinary approach to cancer treatment.The IQQA-BodyImaging extends the 3-D features found in the IQQA product portfolio to thoracic, abdominal and pelvic multimodality scans. Features such as virtual knife for surgery and virtual needle for interventional procedural planning, monitoring and follow-up, provide comprehensive tools for tumor board assessment.The company will also be demonstrating IQQA-Liver Multimodality, as part of the IQQA Product Suite. IQQA-Liver Multimodality is currently being used by physicians worldwide for real-time, interactive treatment planning and post-procedural assessment of liver diseases.Through its proprietary IQQA Web-enabling technology and clinical partnership, EDDA offers OnDemand services for practices to use IQQA applications anytime and anywhere. “Through a combination of technology and in-depth clinical expertise, the MGH 3D Imaging Service offers access to our team of dedicated 3-D technologists to other hospitals and imaging centers with the goal of improving patient care by enhancing the efficiency, reliability, and scalability of 3-D imaging solutions for clinical decision support,” said Gordon J. Harris, Ph.D., director of the 3-D Imaging Service at Massachusetts General Hospital.The IQQA Product Suite also includes IQQA-Guide (work-in-progress) for intraoperative 3-D navigation, IQQA-LiverFunction (work-in-progress) for localized hepatic functional analysis using 3-D SPECT, and IQQA-Chest CAD for small lung nodule detection. EDDA will exhibit its IQQA Platform and Product Suite in booth #4571 at RSNA 2014.For more information: www.eddatech.com FacebookTwitterLinkedInPrint分享 Henry Ford Hospital’s ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology. News | Medical 3-D Printing | August 08, 2019 RSNA and ACR to Collaborate on Landmark Medical 3D Printing Registry The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical… read more center_img Technology | November 24, 2014 EDDA Technology Introduces IQQA-BodyImaging and Cloud-Based OnDemand Services for Imaging-Guided Cancer Treatment IQQA-BodyImaging extends product suite features to thoracic, abdominal and pelvic applications of cancer treatment planning Related Content Technology | Artificial Intelligence | June 20, 2019 TeraRecon Receives First-of-Kind FDA Determination for Northstar AI Results Explorer Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S… read more A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D. Technology | Virtual and Augmented Reality | June 04, 2019 Ann Arbor Startup Launches Augmented Reality MRI Simulator SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially… read more Technology | Virtual and Augmented Reality | June 10, 2019 Medivis SurgicalAR Gets FDA Clearance Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has… read more Image courtesy of Philips Healthcarelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *